Alzheimer and vascular dementia in the elderly patients

Naresh Kumar Seetlani1, Narindar Kumar2, Khalid Imran3

  • 1Naresh Kumar Seetlani, MBBS, FCPS. Assistant Professor, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.

Insights

This study found Alzheimer's disease in 3.79% and vascular dementia in 2.61% of elderly patients. Early detection of these dementias is crucial for better patient outcomes.

Area of Science:

  • Neurology
  • Geriatrics
  • Public Health

Background:

  • Dementia is a significant health concern in the elderly population.
  • Alzheimer's disease and vascular dementia are the most common types of dementia.
  • Understanding the prevalence of these conditions is essential for healthcare planning.

Purpose of the Study:

  • To determine the frequency of Alzheimer's disease and vascular dementia in elderly patients.
  • To assess the prevalence of these neurodegenerative conditions in a specific hospital-based cohort.

Main Methods:

  • A cross-sectional descriptive study was conducted.
  • Patients with dementia symptoms (duration > 6 months, Mini Mental State Examination < 24) were included.
  • Diagnosis was confirmed using CT scans to identify generalized atrophy (Alzheimer's) or stroke (vascular dementia).

Main Results:

  • Out of 422 elderly patients, 3.79% (16) had Alzheimer's disease and 2.61% (11) had vascular dementia.
  • The mean age of patients was 72.58 years.
  • Common comorbidities included hypertension (81.3%) and diabetes (73.7%).

Conclusions:

  • A notable percentage of elderly patients in this study suffered from Alzheimer's disease and vascular dementia.
  • Early diagnosis and timely intervention are recommended to mitigate the impact of dementia.
  • This research highlights the importance of addressing dementia in the elderly population.
Abstract

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
636
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
307
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
569